Count | |
| 3 | |
| 14 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Daunorubicin/*administration & dosage/adverse effects/therapeutic use | 2 |
| 1 | |
| 6 | |
| 1 | |
| 1 | |
| 8 | |
| 1 | |
| 3 | |
| 4 | |
| 4 | |
| 24 | |
| 3 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 36 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Daunorubicin/administration & dosage/*analogs & derivatives/metabolism | 1 |
Daunorubicin/*administration & dosage/adverse effects/pharmacokinetics | 1 |
Daunorubicin/administration & dosage/blood/chemistry/*pharmacokinetics | 1 |
Daunorubicin/analogs & derivatives/*chemical synthesis/metabolism | 1 |
| 2 | |
| 4 | |
| 1 | |
| 2 | |
| 13 | |
| 10 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 27 | |
| 10 | |
| 7 | |
| 1 | |
| 5 | |
| 8 | |
| 12 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 8 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 4 | |
| 12 | |
| 13 | |
| 7 | |
| 9 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 112 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 17 | |
| 28 | |
| 2 | |
| 10 | |
| 14 | |
| 2 | |
| 2 | |
| 6 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 2 | |